Processa Pharmaceuticals (PCSA) Treasury Shares (2013 - 2026)
Processa Pharmaceuticals' (PCSA) quarterly Treasury Shares came in at $300000.0 in Q4 2025, little changed YoY from $300000.0 in Q4 2024, and little changed on a QoQ basis from $300000.0 in Q3 2025.
Processa Pharmaceuticals (PCSA) Treasury Shares (2013 - 2026) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 4 years of Treasury Shares data on file, last reported at $300000.0 in Q4 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $300000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $300000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $300000.0, changed 0.0% from the prior year.
- Treasury Shares was little changed at $300000.0 in Q4 2025, from $300000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $2.2 million in Q3 2023 to a low of -$200.0 in Q4 2023.
- A 5-year average of $474912.0 and a median of $95028.0 in 2024 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 0.0% in 2023, down 0.0% in 2023.
- Tracing PCSA's Treasury Shares over 4 years: stood at $300000.0 in 2022, then changed by 0.0% to $300000.0 in 2023, then changed by 0.0% to $300000.0 in 2024, then changed by 0.0% to $300000.0 in 2025.
- The last three Treasury Shares figures came in at $300000.0 (Q4 2025), $300000.0 (Q3 2025), and $300000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 2.72 Mn |
| 10 | Processa Pharmaceuticals | 5.72 Mn | 5.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45,733.00 |
| Mar 31, 2026 | 45,733.00 |
| Dec 31, 2025 | -200.00 |
| Dec 31, 2025 | -200.00 |
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2025 | 26,064.00 |
| Sep 30, 2025 | 26,064.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 51,380.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 51,380.00 |
| Mar 31, 2025 | 191,313.00 |
| Mar 31, 2025 | 191,313.00 |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | -200.00 |
| Dec 31, 2024 | 300,000.00 |